While global pharmaceutical companies invest 20-25% of their revenues in Research & Development (R&D), Indian companies allocate only around 6-8%. Having a stronger focus on drug discovery can enable ...
AstraZeneca Pharma India Ltd reported a robust performance in Q3FY25, with net profit soaring 94.9% year-on-year (YoY) to ₹30.8 crore from ₹15.8 crore in the same period last year. The company's ...
Other export categories include vaccines, biosimilars, and innovative products such as New Chemical Entities (NCEs) and New Biological Entities (NBEs). India has established itself as a global ...
In India, the incidence of breast cancer has seen a gradual rise, emphasising the need for innovative treatment options. "Last year AstraZeneca Pharma India Limited obtained a dual approval from India ...
Chinese apps make a comeback in India: In 2020, India banned several Chinese apps due to security concerns. However, as relations between India and China have improved, many of these apps have ...
US President Donald Trump questioned the $21 million US allocation for voter turnout in India, during the FII PRIORITY Summit. He highlighted India's strong economy and high tariffs on US goods.
The statement clarified the "sale of Shein branded products in India was not banned", only the Shein app. All e-commerce operations, logistics and marketing will be handled by Reliance ...
The companys institutional business comprises of supplies to various government bodies in India and supply of Anti-Malarial products under WHO approved programs in Africa.Ajanta Pharma operates 7 ...
However, PFAS is widely used in all manner of products, from packaging to clothes. There are industry-wide concerns that such a ban could severely disrupt pharmaceutical supply chains, as PFAS are ...
Imposing a 10 per cent tariff on India's products will likely set off a major price increase cycle in the US generics pharma market. "Given concerns on rising healthcare cost in the US ...
Awareness campaigns were organised for merchants about the need to not use plastic packaging and to not sell banned plastic products, it added. Vehicles entering the Nilgiris at all border ...
By innovating and diversifying its export basket to include specialty generics, biosimilars, and innovative products, the report emphasizes how India can potentially secure a position among the top ...